Arecor Therapeutics
Generated by Meeveem AI
"Developing enhanced medicines for diabetes and cardiometabolic disease through formulation science"
Little Chesterford
•11 - 50 Employees
•Pharmaceuticals
About Arecor Therapeutics
Arecor is a clinical stage biopharmaceutical company using its proprietary Arestat technology platform to reformulate existing therapeutic medicines with enhanced properties. The company develops ultra-concentrated and ultra-fast acting insulins for diabetes, creating patent-protected versions of proven medicines that deliver superior clinical profiles through abbreviated regulatory pathways. By partnering with leading pharmaceutical and medtech companies, Arecor combines its validated formulation platform with industry expertise to bring improved therapeutics to market. The company focuses on diabetes and cardiometabolic diseases, applying its technology to create products with greater safety, convenience, and therapeutic efficacy.
44
Team Members
2007
Founded
Pharmaceuticals
Sector
On-Site
Work Environment
Our Vision
A world where patients access optimised versions of proven medicines, delivered through advanced formulations that enhance therapeutic outcomes and improve daily disease management without the cost and risk of developing entirely new drugs.
Our Mission
At Arecor, our mission is to transform patient care by developing enhanced formulations of existing therapeutic medicines that deliver superior clinical profiles and address significant unmet needs in diabetes and cardiometabolic diseases.